Synthesis and Evaluation of Thiazolidinedione-Coumarin Adducts as Antidiabetic, Anti-Inflammatory and Antioxidant Agents
作者:Garima Mishra、Narsingh Sachan、Pooja Chawla
DOI:10.2174/1570178612666150424235603
日期:2015.6.4
Further, 3-bromoacetyl coumarins (IV) were synthesized using salicylaldehyde and ethylacetoacetate in the presence of piperidine as a catalyst forming 3-acetylcoumarin (III) which was brominated to form 3- bromoacetyl coumarin. Finally, both these compounds i.e., (II) and (IV) were condensed in the presence of dimethyl formamide and potassium carbonate leading to the formation of novel thiazolidine-2,4-dione-coumarin
申请人:Industry-Academic Cooperation Foundation, Chosun University 조선대학교산학협력단(220050171903) BRN ▼408-82-13419
公开号:KR20160126772A
公开(公告)日:2016-11-02
본 개시는 미세조류 파괴용 조성물에 관한 것으로, 상기 미세조류 파괴용 조성물은 해양 미세조류 배양장, 녹조 또는 적조가 발생된 지역 또는 녹조나 적조 발생 예상 지역에 처리되어 미세조류의 생장 및 증식을 억제함으로써, 녹조 및 적조 피해를 예방할 수 있는 효과가 있다.
Effect of thiazolidinedione phenylacetate derivatives on wound-healing activity
作者:So Hee Park、Dubok Choi、Hoon Cho
DOI:10.1007/s12272-018-1041-3
日期:2019.9
The aim of this work was to evaluate the synthesis and structure–activity relationship of 4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenyl 2-phenylacetate derivatives as potential wound-healing agents. The IC50 values of the lead compounds ranged from 0.01 to 0.05 µM. These compounds also increased the levels of extracellular prostaglandin E2 (PGE2) in A549 cells. Among the synthesized compounds, compounds
Synthesis and Structure-activity Relationship Study of 2,4-dioxothiazolidin-5-ylidene Derivatives for 15-hydroxyprostaglandin Dehydrogenase Inhibitory Activity, Prostaglandin E2 Release, and Wound Healing Effect
作者:EunJeong Yoon、DuBok Choi、InSun Yu、Hoon Cho
DOI:10.1007/s12257-021-0071-8
日期:2021.12
The aim of this study was to investigate the synthesis and structure-activityrelationship of 2,4-dioxothiazolidin-5-ylidene derivatives for 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitoryactivity, prostaglandin E2 (PGE2) release, and wound healing effect. Of the synthesized compounds, compound 29 was identified as the best 15-PGDH inhibitor, with an IC50 value of 0.0131 µM. To determine